PUBLISHED DATE : Dec 2022 | Pages : 341
Fill out your details & get your free sample
The Global Body Contouring Devices Market Size, Share, Growth Forecast by:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
341 Pages
105 Tables
211 Charts
5 Regions
20 Countries
37 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 12.62 BILLION |
| Market Size (2021) | USD 5.76 BILLION |
| CAGR ( 2021-2027) | 13.96% |
| Base Year | 2021 |
| Forecast Year | 2027 |
| Market Segments | Application, Gender, Age Group, End-User, and Geography |
| Largest Market | North America |
| Key Vendors | AbbVie, Cutera, Bausch Health Companies, Hologic, and Shanghai Fosun Pharmaceutical |
The global body contouring devices market is expected to cross USD 12.6 billion by 2027 from USD 5.76 billion in 2021, growing at a CAGR of 13.96% from 2022-2027. The growing demand for medical aesthetics treatments is propelling the growth of the body contouring devices market. The medical aesthetic is one of the rapidly growing industries because of the rising aging population and advanced procedure launches that deliver the market a new opportunity for growth. At present, micro-needling and skin tightening treatments are some of the medical aesthetic treatments that are witnessing the highest growth worldwide.
Body contouring devices aim to improve body appearance. Body contouring treatments are MI and non-invasive surgical procedures that enhance body shape and skin texture, such as skin tightening, resurfacing, and other benefits. These procedures require highly skilled medical professionals. Abdominoplasty or liposuction, removal of man breasts, and arm lifts are some procedures performed by body contouring devices.
Some technological advancements made by several companies in body contouring devices include innovations in temperature-controlled fat reduction devices, cellulite treatment devices, non-invasive sclerotherapy treatment, and developments in laser-based techniques. Alma Lasers (FOSUN PHARMA) product, the Accent Prime body contouring device, is used for skin tightening and aesthetic enhancement. Accent Prime merges the latest Ultrasound and RF technologies innovations to deliver effective, highly customized treatments and naturally long-lasting results.
The non-surgical skin tightening is the dominating segment in the application and holds the highest share in the global body contouring devices market; and is estimated to grow at the fastest rate with a CAGR of 14.81% during the forecast period. The rising demand for skin tightening devices is attributed to the increasing aging population, which leads to increasing sagging skin issues and growing concern about skin problems. American Society for Dermatologic Surgery (ASDS) reported that in 2018 about 70% of consumers considered a cosmetic procedure, with 57% specifically considering non-surgical skin tightening treatments. The segment is also experiencing continuous technological advancements.
North America accounts for the highest market share of the global skin resurfacing market owing to the increased adoption of technologically advanced devices, the presence of skilled labor, and higher disposable incomes. APAC is projected to grow faster during the forecast period owing to its increasing economy, medical tourism market, and higher disposable incomes.
The growing obese population has created huge opportunities and demand for liposuction/lipolysis and cellulite treatment devices. Non-surgical fat reduction was in most demand in 2018 after injectables, according to the American Society for Aesthetic Plastic Surgery (ASAPS). However, numerous companies are focused on developing and offering minimally invasive lipolysis devices due to the high complications linked with surgical liposuction procedures and their high cost. For instance, Bausch Health Companies’ Solta Medical and Alma Lasers are now offering next-generation liposuction systems that are minimally invasive (ultrasound and laser).
The demand for non-surgical skin tightening and fat reduction dominates among females. The most common cosmetic procedures that witnessed the highest growth since 2018 among females include botulinum toxin, hyaluronic acid, and non-surgical fat reduction procedures. About 92% of females in the US underwent cosmetic surgeries. In contrast, only 8% of males had cosmetic surgeries in 2020, thus showing females are the dominating consumer population in the global body contouring devices market.
However, in recent years, body contouring treatments have become one of the men's most important procedures. There is a growing demand for jawline contouring, abdominoplasty, and gynecomastia; body contouring treatments have witnessed significant growth among the male population in the last few years.
The 35 and 50 age group dominates the global body contouring devices market under the age group segment. This age group is seeking the most cosmetic procedures, such as liposuction, abdominal fat reduction, and breast reduction. The 35-50 age group is expected to grow at the highest CAGR of 14.35% during the forecast period. In comparison, the segment of the under 34 age group, anti-aging surgical and non-surgical procedures that minimize wrinkles and rejuvenate the face are most popular.
Hospitals and skin clinics dominate the end-user segmentation with the highest body contouring devices market share of 63.31%, as hospitals and skin clinics are the primary care centers in medical aesthetics. This segment is highly adopting minimally invasive body contouring devices. Skin tightening, fat reduction, cellulite treatment, etc., are common procedures performed at hospitals and skin clinics. Medical professionals such as plastic surgeons and dermatologists at hospitals and skin clinics provide patients with a well-scheduled treatment plan.
Medical spas and beauty centers are the second leading end-users of the body contouring devices market. They are anticipated to be the fastest-growing segment, with the highest CAGR of 14.59% during the forecast period. Its growth is attributed to its low cost and convenient treatment plans. Several vendors now offer body contouring devices for skin tightening, skin rejuvenation, and fat reduction products online at affordable costs that individuals can safely use without any instructions or consultations from professionals.
North America holds the highest body contouring devices market share globally, owing to a growing demand for a youthful appearance, an increasingly obese population, and many more. The region has the highest healthcare spending on cosmetics/aesthetic surgeries, ultimately boosting the market growth. In North America, the US holds the highest healthcare spending for medical aesthetic procedures and is also ranked first in the highest surgical and non-surgical aesthetic procedures in 2020. In the same year, the US has the highest number of plastic surgeons (7,000), according to an ISAPS report.
Across Europe, the high demand for cosmetic surgeries is attributable to the growing adoption of energy-based and laser devices for skin tightening and body contouring systems that deliver better results in the market. Body contouring is one of the popular aesthetic treatments in Europe. The increasing obese population, growing awareness among people and advanced medical aesthetics market, and higher adoption of body contouring devices are some key factors fueling the growth of the European body contouring devices market. In addition, the growing trend toward getting an enhanced, youthful physical appearance is also augmenting the demand for body contouring devices.
APAC accounts for the market share of 24.11% in the global body contouring devices market and is expected to witness the highest CAGR growth of 15.18% during the forecast period. The increasing obese population, growing awareness among people, increasing demand for advanced medical aesthetics, and more adoption of body contouring devices are among the key factors fueling the growth of the body contouring devices market in the region. China dominates the body contouring devices market in the region, which is attributable to the increasing older population and rising demand for a youthful appearance. The availability of a large number of aesthetic surgeries, better access, and high healthcare expenditure drive the industry’s growth.
The Latin American region is an emerging market for body contouring devices. In 2020, Brazil showed significant growth in medical aesthetic procedures compared to previous years. Skilled medical professionals and a broad customer base are driving the market growth. The growing medical tourism from other countries in the region is also one of the driving factors for the region's body contouring devices market growth.
However, the high cost of treatments and complications associated with non-surgical body contouring devices hinder the market's overall growth. Also, the lack of technically advanced equipment and skilled professionals to carry out these procedures in low-income countries is likely to hinder the growth of the regional market during the forecast period.
The global body contouring devices market is highly dynamic and competitive. Several international, regional, and local vendors offer a diverse and comprehensive range of body contouring devices with wide applications. Most industry vendors offer a wide range of minimally invasive (MI) body contouring devices. Some of the key vendors in the market include AbbVie, Cutera, Bausch Health Companies, Hologic, and FOSUN PHARMA.
A surge in innovations and investments in developing body contouring devices can be witnessed to increase profits. There is also a surge in product launches in recent years. In 2020, InMode launched its Morpheus8 body multipulse burst RF vulcanization technology, an RF micro-needling device with a minimum penetration of about 7mm. Several next-generation body contouring devices have been developed, and many are in the pipeline. BTL has developed EMSCULPT NEO, released in October 2020. This device combines pulses of the two technologies without heating the magnet and causing a thermal burn. In addition, Emsculpt NEO is a hands-free treatment that can achieve an average of 30% fat reduction and 25% muscle volume growth.
The competition in this global body contouring devices market is expected to strengthen during the forecast period. Leading players have a wide range of product portfolios in various applications, mainly for skin tightening as the aging population is rising. These companies are making huge R&D investments and developing innovative and technologically advanced products. Some prominent vendor activities in the body contouring devices market include:
The leading companies with a strong footprint in the developed nations are strategically expanding their business in low- and middle-income countries, which is attributed to the growing awareness and
Frequently Asked Questions
How big is the body contouring devices market?
The global body contouring devices market size was valued at USD 5.7 billion in 2021 and is expected to reach USD 12.6 billion by 2027.
What is the body contouring devices market growth?
The global body contouring devices market is growing at a CAGR of 13.96% from 2022-2207.
Who are the key players in the global body contouring devices market?
AbbVie, Cutera, Bausch Health Companies, Hologic, and Shanghai Fosun Pharmaceutical are the leading global body contouring devices market companies.
Which region will dominate the global body contouring devices market?
North America holds the largest global body contouring devices market share and is estimated to reach USD 5.24 billion by 2027. The region's higher population of young and adult age group highly contribute to market growth.
What are the factors driving the body contouring devices market?
The technological advancements in body contouring devices, growing interest of males in body contouring, and increasing focus on the development of muscle building and toning devices are the key factors driving the global body contouring devices market.
The global body contouring devices market is expected to grow at a CAGR of approximately 13.96% from 2022 to 2027.
The following factors are likely to contribute to the growth of the global body contouring devices market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the body contouring devices market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Application
Segmentation by Gender
Segmentation by Age Group
Segmentation by End-User
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY APPLICATION
4.3.2 MARKET SEGMENTATION BY GENDER
4.3.3 MARKET SEGMENTATION BY AGE GROUP
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.2 TYPES OF AESTHETIC/COSMETIC PROCEDURES
7.2.1 SURGICAL
7.2.2 NON-SURGICAL
8 PREMIUM INSIGHTS
8.1 MARKET SCENARIO
9 MARKET OPPORTUNITIES & TRENDS
9.1 TECHNOLOGICAL ADVANCES IN BODY CONTOURING DEVICES
9.2 INTEREST OF MEN IN BODY CONTOURING
9.3 FOCUS ON DEVELOPMENT OF MUSCLE-BUILDING & -TONING DEVICES
10 MARKET GROWTH ENABLERS
10.1 FOCUS ON FAT REDUCTION
10.2 DEMAND FOR NON-SURGICAL TREATMENT PROCEDURES
10.3 RISE OF AESTHETIC BUSINESSES & MEDICAL SPAS
11 MARKET RESTRAINTS
11.1 HIGH COST OF TREATMENT
11.2 COMPLICATIONS ASSOCIATED WITH BODY CONTOURING DEVICES
11.3 LACK OF STATUTORY REGULATIONS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY APPLICATION
12.2.2 INSIGHTS BY GENDER
12.2.3 INSIGHTS BY AGE GROUP
12.2.4 INSIGHTS BY END-USER
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 APPLICATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 NON-SURGICAL SKIN TIGHTENING
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 NON-SURGICAL SKIN RESURFACING
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 LIPOSUCTION
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 CELLULITE TREATMENT
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 OTHERS
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
14 GENDER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 FEMALE
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 MALE
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 AGE GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 34–50
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ABOVE 50
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 UNDER 34
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 MEDICAL SPAS & BEAUTY CENTERS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOSPITALS & SKIN CLINICS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 OTHERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA: APPLICATION
18.4 NORTH AMERICA: GENDER
18.5 NORTH AMERICA: AGE GROUP
18.6 NORTH AMERICA: END-USER
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE: APPLICATION
19.4 EUROPE: GENDER
19.5 EUROPE: AGE GROUP
19.6 EUROPE: END-USER
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 ITALY: MARKET SIZE & FORECAST
19.7.3 RUSSIA: MARKET SIZE & FORECAST
19.7.4 SPAIN: MARKET SIZE & FORECAST
19.7.5 FRANCE: MARKET SIZE & FORECAST
19.7.6 UK: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC: APPLICATION
20.4 APAC: GENDER
20.5 APAC: AGE GROUP
20.6 APAC: END-USER
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.4 INDIA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA: APPLICATION
21.4 LATIN AMERICA: GENDER
21.5 LATIN AMERICA: AGE GROUP
21.6 LATIN AMERICA: END-USER
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA: APPLICATION
22.4 MIDDLE EAST & AFRICA: GENDER
22.5 MIDDLE EAST & AFRICA: AGE GROUP
22.6 MIDDLE EAST & AFRICA: END-USER
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 UAE: MARKET SIZE & FORECAST
22.7.4 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 ABBVIE
23.2.2 BAUSCH HEALTH COMPANIES
23.2.3 CUTERA
23.2.4 SHANGHAI FOSUN PHARMA
23.2.5 HOLOGIC
24 KEY COMPANY PROFILES
24.1 ABBVIE
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 BAUSCH HEALTH COMPANIES
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 CUTERA
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 SHANGHAI FOSUN PHARMACEUTICAL
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 HOLOGIC
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 AEROLASE
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ASCLEPION LASER TECHNOLOGIES
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 BEIJING ADSS DEVELOPMENT
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 BIOLITEC
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 BIOTEC ITALIA
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 BISON MEDICAL
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 BRERA MEDICAL TECHNOLOGIES
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 BTL
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 CARTESSA AESTHETICS
25.9.1 BUSINESS OVERVIEW
25.9.2 24.15.2 PRODUCT OFFERINGS
25.10 CANDELA MEDICAL
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 DELEO
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 DOMINION AESTHETIC TECHNOLOGIES
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 EL.EN.
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 ERCHONIA
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 ENDYMED
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 F CARE SYSTEMS
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 FOTONA
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 GSD
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 INMODE
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 LUTRONIC
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 LUMENIS
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 LYNTON LASERS
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 LEAFLIFE TECHNOLOGY
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 MERZ AESTHETICS
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 MICROAIRE SURGICAL INSTRUMENTS
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 MEDART APS
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 PHOTOMEDEX
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 SOFWAVE
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 SCITON
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS
25.30 THERMIGEN
25.30.1 BUSINESS OVERVIEW
25.30.2 PRODUCT OFFERINGS
25.31 VENUS CONCEPT
25.31.1 BUSINESS OVERVIEW
25.31.2 PRODUCT OFFERINGS
25.32 WAVEMED SRL
25.32.1 BUSINESS OVERVIEW
25.32.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY APPLICATION
27.3 MARKET BY GENDER
27.4 MARKET BY AGE GROUP
27.5 MARKET BY END-USER
27.6 NORTH AMERICA BY APPLICATION
27.7 NORTH AMERICA BY GENDER
27.8 NORTH AMERICA BY AGE GROUP
27.9 NORTH AMERICA BY END-USER
27.10 EUROPE BY APPLICATION
27.11 EUROPE BY GENDER
27.12 EUROPE BY AGE GROUP
27.13 EUROPE BY END-USER
27.14 APAC BY APPLICATION
27.15 APAC BY GENDER
27.16 APAC BY AGE GROUP
27.17 APAC BY END-USER
27.18 LATIN AMERICA BY APPLICATION
27.19 LATIN AMERICA BY GENDER
27.20 LATIN AMERICA BY AGE GROUP
27.21 LATIN AMERICA BY END-USER
27.22 MIDDLE EAST & AFRICA BY APPLICATION
27.23 MIDDLE EAST & AFRICA BY GENDER
27.24 MIDDLE EAST & AFRICA BY AGE GROUP
27.25 MIDDLE EAST & AFRICA BY END-USER
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL BODY CONTOURING DEVICES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PLASTIC SURGEONS (2020)
EXHIBIT 4 TOP FIVE SURGICAL PROCEDURES PERFORMED GLOBALLY (2020)
EXHIBIT 5 INVASIVE COSMETIC SURGERIES: TOP FIVE COUNTRIES (2020)
EXHIBIT 6 TOTAL NON-SURGICAL COSMETIC SURGERIES PERFORMED: TOP FIVE COUNTRIES (2020)
EXHIBIT 7 TOTAL NUMBER OF LASER-/LIGHT-/ENERGY-BASED PROCEDURES PERFORMED: US (2012–2019)
EXHIBIT 8 TOTAL NUMBER OF NON-INVASIVE PROCEDURES PERFORMED: US (2014–2019)
EXHIBIT 9 TOTAL NUMBER OF GLOBAL NON-SURGICAL COSMETICS PROCEDURES (2016–2020)
EXHIBIT 10 IMPACT OF TECHNOLOGICAL ADVANCES IN BODY CONTOURING DEVICES
EXHIBIT 11 COMPARISON OF MODALITIES FOR NON-INVASIVE BODY CONTOURING OF ABDOMEN
EXHIBIT 12 IMPACT OF INTEREST OF MEN IN BODY CONTOURING
EXHIBIT 13 GLOBAL INCREASE IN NON-SURGICAL MICRO-ABLATIVE RESURFACING & NON-SURGICAL FAT REDUCTION PROCEDURES PERFORMED ON MEN, 2018–2020 (% SHARE)
EXHIBIT 14 GROWTH IN TOTAL COSMETIC SURGICAL & NON-SURGICAL PROCEDURES AMONG MEN, 2018–2020 (% SHARE)
EXHIBIT 15 IMPACT OF FOCUS ON DEVELOPMENT OF MUSCLE-BUILDING & -TONING DEVICES
EXHIBIT 16 IMPACT OF FOCUS ON FAT REDUCTION
EXHIBIT 17 AGE-ADJUSTED OBESITY PREVALENCE AMONG ADULTS AGED 20 AND OVER: SEX & AGE: US (2017–2018)
EXHIBIT 18 NUMBER OF GLOBAL SURGICAL PROCEDURES: LIPOSUCTION AND ABDOMINOPLASTY PERFORMED BY PLASTIC SURGEONS (2016 & 2019)
EXHIBIT 19 IMPACT OF DEMAND FOR NON-SURGICAL TREATMENT PROCEDURES
EXHIBIT 20 TOTAL NON-SURGICAL PROCEDURES (2020)
EXHIBIT 21 LASER-/LIGHT-/ENERGY-BASED PROCEDURES: US (2014–2020)
EXHIBIT 22 IMPACT OF RISE OF AESTHETIC BUSINESSES & MEDICAL SPAS
EXHIBIT 23 KEY DRIVERS OF MEDICAL AESTHETICS MARKET VALUE
EXHIBIT 24 GLOBAL AESTHETIC MEDICINE INDUSTRY MARKET SIZE (2015–2019) ($ BILLION)
EXHIBIT 25 AESTHETICS INJECTABLES MARKET INNOVATION CLUSTERS (2015–2021)
EXHIBIT 26 IMPACT OF HIGH COST OF TREATMENT
EXHIBIT 27 IMPACT OF COMPLICATIONS ASSOCIATED WITH BODY CONTOURING DEVICES
EXHIBIT 28 IMPACT OF LACK OF STATUTORY REGULATIONS
EXHIBIT 29 IMPACT OF REGULATIONS ON MARKET GROWTH
EXHIBIT 30 GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 31 APPLICATION: GLOBAL BODY CONTOURING DEVICES MARKET, 2021 & 2027 (%)
EXHIBIT 32 GENDER: GLOBAL BODY CONTOURING DEVICES MARKET, 2021 & 2027 (%)
EXHIBIT 33 AGE GROUP: GLOBAL BODY CONTOURING DEVICES MARKET, 2021 & 2027 (%)
EXHIBIT 34 END-USER: GLOBAL BODY CONTOURING DEVICES MARKET, 2021 & 2027 (%)
EXHIBIT 35 GEOGRAPHY: GLOBAL BODY CONTOURING DEVICES MARKET, 2021 & 2027 (%)
EXHIBIT 36 FIVE FORCES ANALYSIS 2021
EXHIBIT 37 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 38 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION
EXHIBIT 39 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 40 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 41 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION – MARKET OVERVIEW (2021–2027)
EXHIBIT 42 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION – MARKET GROWTH ANALYSIS (2021–2027)
EXHIBIT 43 GLOBAL BODY CONTOURING DEVICES MARKET BY NON-SURGICAL SKIN TIGHTENING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 PERCENTAGE OF PLASTIC SURGEONS PERFORMING NON-SURGICAL SKIN TIGHTENING PROCEDURES BY COUNTRIES (2020)
EXHIBIT 45 NON-SURGICAL SKIN TIGHTENING: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 46 NON-SURGICAL SKIN TIGHTENING: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 47 GLOBAL BODY CONTOURING DEVICES MARKET BY NON-SURGICAL SKIN RESURFACING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 NON-SURGICAL SKIN RESURFACING: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 49 NON-SURGICAL SKIN RESURFACING: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 50 GROWTH OF LIPOSUCTION PROCEDURES (2018–2020)
EXHIBIT 51 GLOBAL BODY CONTOURING DEVICES MARKET BY LIPOSUCTION: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 LIPOSUCTION: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 53 LIPOSUCTION: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 54 GLOBAL PERCENTAGE OF PLASTIC SURGEONS WHO PERFORM CELLULITE TREATMENT (2018–2020)
EXHIBIT 55 GLOBAL BODY CONTOURING DEVICES MARKET BY CELLULITE TREATMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 CELLULITE TREATMENT: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 CELLULITE TREATMENT: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 58 TOTAL INJECTABLES PROCEDURES BY COUNTRIES (2020)
EXHIBIT 59 DECLINING GASTRIC BAND PROCEDURES PERFORMED: US (2016–2020)
EXHIBIT 60 GLOBAL BODY CONTOURING DEVICES MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 OTHERS: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 62 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 63 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 64 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER
EXHIBIT 65 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 66 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER: ABSOLUTE GROWTH (%)
EXHIBIT 67 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER – MARKET OVERVIEW (2021 & 2027)
EXHIBIT 68 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER – MARKET GROWTH ANALYSIS (2021 & 2027)
EXHIBIT 69 TOTAL GLOBAL NON-SURGICAL PROCEDURES PERFORMED: FEMALE & MALE (2018 & 2020)
EXHIBIT 70 FEMALE: TOTAL GLOBAL SURGICAL & NON-SURGICAL COSMETICS PROCEDURES PERFORMED (2018–2020)
EXHIBIT 71 GLOBAL BODY CONTOURING DEVICES MARKET BY FEMALE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 72 FEMALE: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 73 FEMALE: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 74 MALE: TOTAL SURGICAL & NON-SURGICAL COSMETICS PROCEDURES (2018–2020)
EXHIBIT 75 GLOBAL BODY CONTOURING DEVICES MARKET BY MALE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 MALE: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 77 MALE: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 78 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 79 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP
EXHIBIT 80 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 81 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP: ABSOLUTE GROWTH (%)
EXHIBIT 82 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP – MARKET OVERVIEW (2021 & 2027)
EXHIBIT 83 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP – MARKET GROWTH ANALYSIS (2021 & 2027)
EXHIBIT 84 GLOBAL BODY CONTOURING DEVICES MARKET BY 34–50: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 34–50: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 86 34–50: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 87 GLOBAL BODY CONTOURING DEVICES MARKET BY ABOVE 50: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 88 ABOVE 50: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 89 ABOVE 50: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 90 GLOBAL BODY CONTOURING DEVICES MARKET BY UNDER 34: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 UNDER 34: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 92 UNDER 34: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 93 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 94 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER
EXHIBIT 95 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 96 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 97 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER – MARKET GROWTH ANALYSIS (2021 & 2027)
EXHIBIT 98 GLOBAL BODY CONTOURING DEVICES MARKET BY MEDICAL SPAS & BEAUTY CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 MEDICAL AESTHETIC TREATMENTS AT MEDICAL SPAS & BEAUTY CENTERS
EXHIBIT 100 MEDICAL SPAS & BEAUTY CENTERS: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 101 MEDICAL SPAS & BEAUTY CENTERS: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 102 COSMETIC & RECONSTRUCTIVE PROCEDURES PERFORMED IN HOSPITALS (2020) (MILLION)
EXHIBIT 103 GLOBAL BODY CONTOURING DEVICES MARKET BY HOSPITALS & SKIN CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 104 HOSPITALS & SKIN CLINICS: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 105 HOSPITALS & SKIN CLINICS: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 106 GLOBAL BODY CONTOURING DEVICES MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 107 OTHERS: GLOBAL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 109 INCREMENTAL GROWTH BY GEOGRAPHY (2021 & 2027)
EXHIBIT 110 GLOBAL BODY CONTOURING DEVICES MARKET BY GEOGRAPHY
EXHIBIT 111 GLOBAL BODY CONTOURING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 112 GLOBAL BODY CONTOURING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 113 PERCENTAGE OF FOREIGN PATIENTS (MEDICAL TOURISM) (2020)
EXHIBIT 114 NORTH AMERICA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 NORTH AMERICA BODY CONTOURING DEVICES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 116 NORTH AMERICA BODY CONTOURING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 117 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 118 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 119 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 120 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 121 INCREMENTAL GROWTH IN NORTH AMERICA (2021 & 2027)
EXHIBIT 122 US: PERCENTAGE CHANGE IN COSMETIC PROCEDURES (2020 VS. 2019)
EXHIBIT 123 ESTIMATED NUMBER OF PLASTIC SURGEONS (2020)
EXHIBIT 124 US: MINIMALLY INVASIVE COSMETIC PROCEDURES (NON-INVASIVE FAT REDUCTION & NON-SURGICAL SKIN TIGHTENING) (2018–2020)
EXHIBIT 125 US: IMPACT OF COVID-19 PANDEMIC ON MINIMALLY INVASIVE COSMETIC PROCEDURES (2017–2020)
EXHIBIT 126 US: LASER SKIN RESURFACING PROCEDURES (2018–2020)
EXHIBIT 127 US BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 128 CANADIAN PLASTIC SURGEONS PROVIDING AESTHETIC SERVICES (2018) (ABSOLUTE FREQUENCY)
EXHIBIT 129 CANADA BODY CONTOURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 130 EUROPE BODY CONTOURING DEVICES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 131 EUROPE BODY CONTOURING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 132 EUROPE BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 133 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 134 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 135 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 136 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 137 INCREMENTAL GROWTH IN EUROPE (2021 & 2027)
EXHIBIT 138 GERMANY: OBESITY PREVALENCE (2019)
EXHIBIT 139 GERMANY: PERCENTAGE INCREASE IN TOTAL AESTHETIC SURGICAL & NON-SURGICAL PROCEDURES (2018–2020)
EXHIBIT 140 GERMANY: AESTHETIC SURGICAL & NON-SURGICAL BODY CONTOURING PROCEDURES (2018–2020)
EXHIBIT 141 GERMANY BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 142 ITALY: TOTAL COSMETIC SURGICAL & NON-SURGICAL PROCEDURES (2018–2020)
EXHIBIT 143 ITALY: NON-SURGICAL PROCEDURES (2018–2020)
EXHIBIT 144 ITALY BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 145 RUSSIA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 146 SPAIN: TOTAL COSMETIC SURGICAL & NON-SURGICAL PROCEDURES (2019–2020)
EXHIBIT 147 SPAIN: COSMETIC SURGERY COST SAVING (2020)
EXHIBIT 148 SPAIN BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 149 FRANCE: TOTAL COSMETIC SURGICAL & NON-SURGICAL PROCEDURES (2020)
EXHIBIT 150 FRANCE: MOST COMMON AESTHETIC SURGICAL & NON-SURGICAL PROCEDURES (2019)
EXHIBIT 151 FRANCE BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 152 UK: MOST COMMON SURGICAL COSMETIC PROCEDURES (2019)
EXHIBIT 153 UK BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 154 APAC BODY CONTOURING DEVICES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 155 APAC BODY CONTOURING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 156 APAC BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 157 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 158 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 159 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 160 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 161 INCREMENTAL GROWTH IN APAC (2021 & 2027)
EXHIBIT 162 CHINA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 163 JAPAN: TOTAL SURGICAL & NON-SURGICAL COSMETIC PROCEDURES (2019)
EXHIBIT 164 JAPAN BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 165 SOUTH KOREA: OBESITY PREVALENCE (2018) (%)
EXHIBIT 166 SOUTH KOREA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 167 IMPACT OF COVID-19 PANDEMIC ON SURGICAL & NON-SURGICAL AESTHETIC PROCEDURES (2018–2020)
EXHIBIT 168 INDIA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 169 AUSTRALIA: OBESITY PREVALENCE (2017–2018) (%)
EXHIBIT 170 AUSTRALIA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 171 LATIN AMERICA BODY CONTOURING DEVICES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 172 LATIN AMERICA BODY CONTOURING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 173 LATIN AMERICA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 174 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 175 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 176 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 177 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 178 INCREMENTAL GROWTH IN LATIN AMERICA (2021 & 2027)
EXHIBIT 179 BRAZIL: TOTAL SURGICAL & NON-SURGICAL PROCEDURES (2018–2020)
EXHIBIT 180 BRAZIL BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 181 MEXICO: TOTAL SURGICAL & NON-SURGICAL COSMETIC PROCEDURES (2019 & 2020)
EXHIBIT 182 MEXICO BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 183 ARGENTINA: PERCENTAGE INCREASE IN TOTAL SURGICAL & NON-SURGICAL COSMETIC PROCEDURES (2019–2020)
EXHIBIT 184 ARGENTINA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 185 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 186 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 187 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 188 INCREMENTAL GROWTH BY APPLICATION (2021 & 2027)
EXHIBIT 189 INCREMENTAL GROWTH BY GENDER (2021 & 2027)
EXHIBIT 190 INCREMENTAL GROWTH BY AGE GROUP (2021 & 2027)
EXHIBIT 191 INCREMENTAL GROWTH BY END-USER (2021 & 2027)
EXHIBIT 192 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2021 & 2027)
EXHIBIT 193 TURKEY: PERCENT INCREASE IN TOTAL SURGICAL & NON-SURGICAL COSMETIC PROCEDURES (2019–2020)
EXHIBIT 194 TURKEY BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 195 SAUDI ARABIA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 196 UAE BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 197 SOUTH AFRICA BODY CONTOURING DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 198 GLOBAL BODY CONTOURING DEVICES MARKET – PURE & DIVERSIFIED PLAYERS
EXHIBIT 199 GLOBAL BODY CONTOURING DEVICES MARKET – MARKET DOMINANCE ANALYSIS
EXHIBIT 200 GLOBAL BODY CONTOURING DEVICES MARKET – CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 201 ABBVIE: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 202 ABBVIE: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 203 ABBVIE: AESTHETICS SEGMENT BREAKDOWN, BY REVENUE, 2019–2021 ($ MILLION)
EXHIBIT 204 ABBVIE: MARKET SHARE BY GEOGRAPHY, 2021 (%)
EXHIBIT 205 BAUSCH HEALTH COMPANIES: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 206 BAUSCH HEALTH COMPANIES: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 207 CUTERA: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 208 CUTERA: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 209 CUTERA: MARKET SHARE BY GEOGRAPHY (2021) (%)
EXHIBIT 210 SHANGHAI FOSUN PHARMACEUTICAL: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 211 HOLOGIC: TOTAL REVENUE 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 TOTAL SURGICAL PROCEDURES PERFORMED GLOBALLY (2018–2020)
TABLE 4 TOTAL NUMBER OF TOP FIVE NON-SURGICAL PROCEDURES PERFORMED GLOBALLY (2018–2020)
TABLE 5 RECOMMENDED BODY FAT PERCENTAGE BY AGE AND GENDER
TABLE 6 GLOBAL PERCENT CHANGE IN GROWTH OF NON-SURGICAL PROCEDURES (2016–2020)
TABLE 7 COSTS OF BODY CONTOURING DEVICES
TABLE 8 APPEARANCE ENHANCEMENT LICENSES FOR PROCEDURAL SERVICES
TABLE 9 TOTAL FACIAL REJUVENATION PROCEDURES PERFORMED GLOBALLY (2018–2020)
TABLE 10 TOTAL PHOTO-REJUVENATION PROCEDURES BY COUNTRIES (2018–2020)
TABLE 11 TOTAL INJECTABLE COSMETICS PROCEDURES PERFORMED GLOBALLY (2016, 2019 & 2020)
TABLE 12 TYPES OF NON-SURGICAL COSMETIC PROCEDURES: FEMALE AND MALE (2020)
TABLE 13 SURGICAL & NON-SURGICAL PROCEDURES: WOMEN (2020)
TABLE 14 MOST COMMON NON-SURGICAL COSMETIC PROCEDURES PER AGE GROUP (2020)
TABLE 15 34–50: TOTAL NUMBER OF COSMETICS PROCEDURES PERFORMED GLOBALLY (2018 & 2020)
TABLE 16 ABOVE 50: TOTAL NUMBER OF COSMETICS PROCEDURES PERFORMED GLOBALLY (2018 & 2020)
TABLE 17 UNDER 34: TOTAL NUMBER OF COSMETICS PROCEDURES PERFORMED GLOBALLY (2018 & 2020)
TABLE 18 ITALY: TOTAL COSMETIC SURGERIES PERFORMED (2019 & 2020)
TABLE 19 ABBVIE: MAJOR PRODUCT OFFERINGS
TABLE 20 BAUSCH HEALTH COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 21 CUTERA: MAJOR PRODUCT OFFERINGS
TABLE 22 SHANGHAI FOSUN PHARMACEUTICAL: MAJOR PRODUCT OFFERINGS
TABLE 23 HOLOGIC: MAJOR PRODUCT OFFERINGS
TABLE 24 AEROLASE: MAJOR PRODUCT OFFERINGS
TABLE 25 ASCLEPION LASER TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 26 BEIJING ADSS DEVELOPMENT: MAJOR PRODUCT OFFERINGS
TABLE 27 BIOLITEC: MAJOR PRODUCT OFFERINGS
TABLE 28 BIOTEC ITALIA: MAJOR PRODUCT OFFERINGS
TABLE 29 BISON MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 30 BRERA MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 31 BTL MAJOR PRODUCT OFFERINGS
TABLE 32 CARTESSA AESTHETICS: MAJOR PRODUCT OFFERINGS
TABLE 33 CANDELA MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 34 DELEO: MAJOR PRODUCT OFFERINGS
TABLE 35 DOMINION AESTHETIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 36 EL.EN.: MAJOR PRODUCT OFFERINGS
TABLE 37 ERCHONIA: MAJOR PRODUCT OFFERINGS
TABLE 38 ENDYMED: MAJOR PRODUCT OFFERINGS
TABLE 39 F CARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 40 FOTONA: MAJOR PRODUCT OFFERINGS
TABLE 41 GSD: MAJOR PRODUCT OFFERINGS
TABLE 42 INMODE: MAJOR PRODUCT OFFERINGS
TABLE 43 LUTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 44 LUMENIS: MAJOR PRODUCT OFFERINGS
TABLE 45 LYNTON LASERS: MAJOR PRODUCT OFFERINGS
TABLE 46 LEAFLIFE TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 47 MERZ AESTHETICS: MAJOR PRODUCT OFFERINGS
TABLE 48 MICROAIRE SURGICAL INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 49 MEDART APS: MAJOR PRODUCT OFFERINGS
TABLE 50 PHOTOMEDEX: MAJOR PRODUCT OFFERINGS
TABLE 51 SOFWAVE: MAJOR PRODUCT OFFERINGS
TABLE 52 SCITON: MAJOR PRODUCT OFFERINGS
TABLE 53 THERMIGEN: MAJOR PRODUCT OFFERINGS
TABLE 54 VENUS CONCEPT: MAJOR PRODUCT OFFERINGS
TABLE 55 WAVEMED SRL: MAJOR PRODUCT OFFERINGS
TABLE 56 GLOBAL BODY CONTOURING DEVICES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 57 GLOBAL BODY CONTOURING DEVICES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 58 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 59 GLOBAL BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 60 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 61 GLOBAL BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 62 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 63 GLOBAL BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 64 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 65 GLOBAL BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 66 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 67 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 68 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 69 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 70 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 71 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 72 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 73 NORTH AMERICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 74 EUROPE BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 75 EUROPE BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 76 EUROPE BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 77 EUROPE BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 78 EUROPE BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 79 EUROPE BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 80 EUROPE BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 81 EUROPE BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 82 APAC BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 83 APAC BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 84 APAC BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 85 APAC BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 86 APAC BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 87 APAC BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 88 APAC BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 89 APAC BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 90 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 91 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 92 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 93 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 94 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 95 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 96 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 97 LATIN AMERICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
TABLE 98 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 99 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY APPLICATION 2021–2027 (%)
TABLE 100 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 101 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY GENDER 2021–2027 (%)
TABLE 102 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 ($ MILLION)
TABLE 103 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY AGE GROUP 2021–2027 (%)
TABLE 104 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 105 MIDDLE EAST & AFRICA BODY CONTOURING DEVICES MARKET BY END-USER 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
